---
layout: post
title: "Development of Local Anesthetic Drug Products With Prolonged Duration of Effect; Draft Guidance for Industry; Availability"
date: 2026-02-05 18:35:55 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-05396
original_published: 2023-03-16 00:00:00 +0000
significance: 8.00
---

# Development of Local Anesthetic Drug Products With Prolonged Duration of Effect; Draft Guidance for Industry; Availability

**Published:** February 05, 2026 18:35 UTC
**Source:** Federal Register
**Original Published:** March 16, 2023 00:00 UTC
**Document Number:** 2023-05396

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Development of Local Anesthetic Drug Products With Prolonged Duration of Effect." The draft guidance reflects the Agency's current recommendations regarding drug development and trial design issues relevant to the study of local anesthetic drug products with prolonged duration of effect for which submission of a new drug application (NDA) is planned. The recommendations in the guidance are intended to assist developers in generating the data necessary to support different indications and labeling claims for these drugs.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/03/16/2023-05396/development-of-local-anesthetic-drug-products-with-prolonged-duration-of-effect-draft-guidance-for)
- API: https://www.federalregister.gov/api/v1/documents/2023-05396

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
